Taiwan FDA registration f8b0035620efa86d6c5c1fad284e7437

Norfaferite cytomegalovirus immunoglobulin M enzyme immunoassay kit

TW: 諾法鐵巨細胞病毒免疫球蛋白M酵素免疫分析試劑套組
Taiwan flagTaiwan·Risk Class 2·GOLD STANDARD DIAGNOSTICS FRANKFURT GMBH·Registered Dec 09, 2021 – Dec 09, 2026Active
Registration details
Analysis ID
f8b0035620efa86d6c5c1fad284e7437
Customs Code
DHA05603491807
Company information
Manufacturer Country
Germany
Authorized Representative
EVERLIGHT BIOTECH(TAIWAN) CO., LTD.
Product details
Intended Use
This kit is used for the qualitative detection of anti-cytomegalovirus (CMV) immunoglobulin M antibodies in human serum or plasma (citric acid, heparin).
Product Type (Level 1)
C Immunology and microbiology
Product Type (Level 2)
C.3175 巨細胞病毒血清試劑
Import Information
QMS/QSD;; 輸入
Dates and status
Registration Date
Dec 09, 2021
Expiry Date
Dec 09, 2026
About this record

Access comprehensive regulatory information for Norfaferite cytomegalovirus immunoglobulin M enzyme immunoassay kit in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number f8b0035620efa86d6c5c1fad284e7437 and manufactured by GOLD STANDARD DIAGNOSTICS FRANKFURT GMBH. The authorized representative in Taiwan is EVERLIGHT BIOTECH(TAIWAN) CO., LTD..

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.

Free DatabasePowered by Pure Global AI89,000+ Devices